TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen

Centers for Disease Control and Prevention43 个研究点分布在 2 个国家目标入组 215 人开始时间: 1999年2月最近更新: 2005年9月5日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Centers for Disease Control and Prevention
入组人数: 215
试验地点: 43
主要终点: Rate of confirmed treatment failure and relapse

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Primary objective:

To determine the rate of confirmed treatment failure and relapse with an intermittent rifabutin-based regimen for the treatment of isoniazid and rifamycin-susceptible HIV-related tuberculosis (TB).

研究设计

研究类型: Interventional
分配方式: Non Randomized
干预模型: Single Group
主要目的: Treatment
盲法: None

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

未提供

排除标准

未提供

结局指标

主要结局

Rate of confirmed treatment failure and relapse

次要结局

Safety and tolerability
Response of HIV RNA to TB treatment
Paradoxical reactions

研究者

发起方

Centers for Disease Control and Prevention

申办方类型

Fed

研究点 (43)

Loading locations...

相似试验

已完成

2 期

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TBHIV InfectionsTuberculosis

NCT00023348Centers for Disease Control and Prevention150

已完成

3 期

Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated TuberculosisAcquired Immunodeficiency SyndromeTuberculosisHIV Infections

NCT00698334All India Institute of Medical Sciences, New Delhi150

已完成

不适用

Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children (TB-Speed HIV)HIVTuberculosis

NCT04121026Institut National de la Santé Et de la Recherche Médicale, France278

已完成

3 期

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)TuberculosisHIV Infections

NCT01404312National Institute of Allergy and Infectious Diseases (NIAID)3,000

Unknown

4 期

Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment OutcomesAIDS With Tuberculosis

NCT01782950Makerere University400